Amlodipine BesylateMeSH concept

http://www.lecrat.eu/?s=Amlodipine+-+AMLOR%C2%AE
2014
France
French
amlodipine
pregnancy
calcium channel blockers
antihypertensive agents
breast feeding
amlodipine
Amlodipine Besylate
drug information

---
http://www.has-sante.fr/portail/jcms/c_1750090/fr/coveram
http://www.has-sante.fr/portail/jcms/c_840942/coveram
2014
false
France
French
amlodipine
Amlodipine Besylate
arginine
perindopril
amlodipine
arginine
perindopril
amlodipine, perindopril drug combination
antihypertensive agents
amlodipine, perindopril drug combination
amlodipine
drug combinations
perindopril and amlodipine
perindopril
administration, oral
insurance, health, reimbursement
treatment outcome
hypertension
coronary artery disease
calcium channel blockers
angiotensin-converting enzyme inhibitors
Amlodipine Besylate
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1742454/fr/natrixam
2014
France
French
administration, oral
drug combinations
insurance, health, reimbursement
hypertension
indapamide
indapamide
Amlodipine Besylate
Amlodipine Besylate
antihypertensive agents
antihypertensive agents
amlodipine and diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
calcium channel blockers
calcium channel blockers
treatment outcome
evaluation of the transparency committee
amlodipine
amlodipine

---
http://www.ansm.sante.fr/var/ansm_site/storage/original/application/2bddb5ad32111b08b86144a1d1d71caa.pdf
false
France
French
Atorvastatin
treatment outcome
antihypertensive agents
cardiovascular diseases
risk factors
amlodipine, atorvastatin drug combination
amlodipine
administration, oral
hydroxymethylglutaryl-coa reductase inhibitors
calcium channel blockers
tablets
drug combinations
atorvastatin and amlodipine
drug evaluation
Amlodipine Besylate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67815898
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
amlodipine
Amlodipine Besylate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63370963
2012
France
summary of product characteristics
package leaflet
tablets
Amlodipine Besylate
hydrochlorothiazide
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63460503
2012
France
summary of product characteristics
package leaflet
tablets
Amlodipine Besylate
hydrochlorothiazide
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60771292
2012
France
summary of product characteristics
package leaflet
Amlodipine Besylate
hydrochlorothiazide
amlodipine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68994137
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
Amlodipine Besylate
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69684554
2012
France
summary of product characteristics
package leaflet
Amlodipine Besylate
hydrochlorothiazide
tablets
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69895640
2012
France
summary of product characteristics
package leaflet
Amlodipine Besylate
amlodipine
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69531131
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
Amlodipine Besylate
amlodipine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68582945
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
Amlodipine Besylate
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66704731
2012
France
summary of product characteristics
package leaflet
amlodipine
tablets
hydrochlorothiazide
Amlodipine Besylate

---
http://www.has-sante.fr/portail/jcms/c_1294042/exforge-hct-synthese-28032012
http://www.has-sante.fr/portail/jcms/c_1251529/exforge-hct-28032012-avis-ct11985
http://www.has-sante.fr/portail/jcms/c_1294106/exforge-hct-association-fixe-amlodipine/valsartan/hydrochlorothiazide
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
Valsartan
antihypertensive agents
diuretics
hypertension
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
adult
aged
randomized controlled trials as topic
diastolic pressure
systolic pressure
blood pressure
hydrochlorothiazide
exforge HCT
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
amlodipine
comparative study

---
http://www.has-sante.fr/portail/jcms/c_944504/exforge-hct
http://www.has-sante.fr/portail/jcms/c_1250041/exforge-hct
2012
false
France
French
evaluation of the transparency committee
Valsartan
exforge HCT
drug combinations
administration, oral
insurance, health, reimbursement
hydrochlorothiazide
amlodipine
Amlodipine Besylate
valsartan, amlodipine and hydrochlorothiazide
hypertension
adult
aged
treatment outcome
clinical trials, phase iii as topic
antihypertensive agents

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/twynsta-1441.html
2012
false
Canada
English
French
evaluation of the transparency committee
Cost-Benefit analysis
telmisartan amlodipine combination
amlodipine
drug combinations
administration, oral
hypertension
telmisartan and amlodipine
treatment outcome
angiotensin II type 1 receptor blockers
antihypertensive agents
calcium channel blockers
benzimidazoles
benzoates
Amlodipine Besylate
drug evaluation
Telmisartan

---
https://www.ema.europa.eu/medicines/human/EPAR/Rasitrio
2012
false
United Kingdom
English
French
drug evaluation
summary of product characteristics
package leaflet
syndication feed
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing aliskiren and amlodipine and hydrochlorothiazide (medicinal product)
amides
amides
fumarates
fumarates
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
hydrochlorothiazide
aliskiren
amlodipine
drug combinations
aliskiren
amlodipine
hydrochlorothiazide
antihypertensive agents
antihypertensive agents
renin
aliskiren, amlodipine and hydrochlorothiazide
calcium channel blockers
calcium channel blockers
administration, oral
adult
hypertension
drug approval
treatment outcome
diuretics
diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
vasodilator agents
vasodilator agents
Amlodipine Besylate

---
https://www.ema.europa.eu/medicines/human/EPAR/Rasilamlo
2012
United Kingdom
French
English
summary of product characteristics
package leaflet
drug evaluation
syndication feed
Amlodipine Besylate
aliskiren
amlodipine
drug combinations
administration, oral
aliskiren
amlodipine
hypertension
adult
amides
amides
fumarates
fumarates
antihypertensive agents
antihypertensive agents
renin
calcium channel blockers
calcium channel blockers
vasodilator agents
vasodilator agents
aliskiren and amlodipine
treatment outcome
drug approval
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
http://www.has-sante.fr/portail/display.jsp?id=c_555131
http://www.has-sante.fr/portail/jcms/c_1263605/amlor
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/amlor_06062012_avis_ct12184.pdf
2012
France
French
amlodipine
administration, oral
antihypertensive agents
vasodilator agents
calcium channel blockers
amlodipine
hypertension
angina pectoris
insurance, health, reimbursement
Amlodipine Besylate
Amlodipine Besylate
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Twynsta
2012
United Kingdom
English
French
syndication feed
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
administration, oral
drug combinations
drug approval
treatment outcome
amlodipine
amlodipine
benzimidazoles
benzimidazoles
benzoates
benzoates
hypertension
adult
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
calcium channel blockers
calcium channel blockers
telmisartan and amlodipine
benzimidazoles
benzoates
telmisartan amlodipine combination
telmisartan amlodipine combination
Amlodipine Besylate
package leaflet
summary of product characteristics
drug evaluation
Telmisartan
Telmisartan

---
https://www.ema.europa.eu/medicines/human/EPAR/Dafiro-HCT
2012
false
United Kingdom
English
French
syndication feed
Valsartan
Valsartan
breast feeding
drug evaluation, preclinical
drug combinations
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
antihypertensive agents
amlodipine
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
drug approval
drug labeling
treatment outcome
tablets
administration, oral
adult
aged
drug interactions
pregnancy
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
Product containing amlodipine and hydrochlorothiazide and valsartan (medicinal product)
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Exforge-HCT
2012
false
United Kingdom
French
English
syndication feed
Valsartan
Valsartan
drug labeling
treatment outcome
drug approval
administration, oral
adult
aged
diuretics
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
angiotensin II type 1 receptor blockers
amlodipine
antihypertensive agents
sodium chloride symporter inhibitors
hydrochlorothiazide
amlodipine
antihypertensive agents
sodium chloride symporter inhibitors
calcium channel blockers
diuretics
hydrochlorothiazide
angiotensin II type 1 receptor blockers
calcium channel blockers
drug combinations
valsartan, amlodipine and hydrochlorothiazide
exforge HCT
Amlodipine Besylate
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Imprida-HCT
2012
false
United Kingdom
English
French
syndication feed
Valsartan
Valsartan
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
drug combinations
drug labeling
treatment outcome
tablets
administration, oral
adult
drug approval
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
summary of product characteristics
drug evaluation
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Copalia-HCT
2012
false
United Kingdom
English
French
syndication feed
Valsartan
Valsartan
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
amlodipine
hydrochlorothiazide
antihypertensive agents
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
diuretics
calcium channel blockers
sodium chloride symporter inhibitors
tablets
administration, oral
adult
drug approval
drug labeling
treatment outcome
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug combinations
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
Product containing amlodipine and hydrochlorothiazide and valsartan (medicinal product)
summary of product characteristics
drug evaluation
package leaflet

---
https://minerva-ebp.be/fr/article/204
2011
false
false
minerva-ebm.be
Belgium
French
Dutch
critical appraisal or critical reading
amides
fumarates
aliskiren and amlodipine
aliskiren
amlodipine
Amlodipine Besylate
hypertension
aliskiren
amlodipine
antihypertensive agents
calcium channel blockers
drug therapy, combination
renin
drug combinations
double-blind method

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-04/exforge_hct-_ct-7151.pdf
http://www.has-sante.fr/portail/jcms/c_966568/exforge-hct-association-fixe-damlodipine/valsartan/hydrochlorothiazide-antihypertenseur
2010
false
France
French
Valsartan
drug combinations
amlodipine
hydrochlorothiazide
administration, oral
insurance, health, reimbursement
valsartan, amlodipine and hydrochlorothiazide
hypertension
adult
treatment outcome
antihypertensive agents
exforge HCT
Amlodipine Besylate
evaluation of the transparency committee
guidelines for drug use

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63123849
2010
France
French
tablets
administration, oral
drug combinations
amlodipine
amlodipine
amlodipine, atorvastatin drug combination
amlodipine, atorvastatin drug combination
heptanoic acids
heptanoic acids
pyrroles
pyrroles
cardiovascular diseases
risk factors
adult
aged
drug interactions
pregnancy
breast feeding
atorvastatin and amlodipine
hydroxymethylglutaryl-coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
calcium channel blockers
calcium channel blockers
antihypertensive agents
antihypertensive agents
anticholesteremic agents
anticholesteremic agents
drug evaluation, preclinical
hypertension
heptanoic acids
pyrroles
atorvastatin calcium
atorvastatin calcium
Amlodipine Besylate
package leaflet
summary of product characteristics
Amlodipine Besylate

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/twynsta_-_ct_9341.pdf
http://www.has-sante.fr/portail/jcms/c_1013263/twynsta
2010
France
French
evaluation of the transparency committee
treatment outcome
adult
hypertension
drug combinations
administration, oral
insurance, health, reimbursement
angiotensin II type 1 receptor blockers
amlodipine
benzimidazoles
benzoates
antihypertensive agents
calcium channel blockers
telmisartan and amlodipine
benzimidazoles
benzoates
telmisartan amlodipine combination
Amlodipine Besylate
Telmisartan

---
http://www.has-sante.fr/portail/jcms/c_841132/coveram-ct-6938
http://www.has-sante.fr/portail/jcms/c_874941/synthese-d-avis-coveram-ct-6938
http://www.has-sante.fr/portail/jcms/c_874943/coveram-association-fixe-de-perindopril-arginine-et-damlodipine-antihypertenseur
2009
France
French
antihypertensive agents
amlodipine, perindopril drug combination
amlodipine
drug combinations
perindopril and amlodipine
perindopril
administration, oral
insurance, health, reimbursement
treatment outcome
hypertension
coronary artery disease
calcium channel blockers
angiotensin-converting enzyme inhibitors
Amlodipine Besylate
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/display.jsp?id=c_522785
http://www.has-sante.fr/portail/upload/docs/application/pdf/caduet.pdf
2007
false
France
French
Atorvastatin
amlodipine
antihypertensive agents
hypertension
treatment outcome
drug combinations
atorvastatin and amlodipine
amlodipine, atorvastatin drug combination
Amlodipine Besylate
guidelines for drug use

---
https://minerva-ebp.be/fr/article/674
2006
false
false
minerva-ebm.be
Belgium
French
comparative study
amlodipine
heart diseases
antihypertensive agents
calcium channel blockers
perindopril
angiotensin-converting enzyme inhibitors
atenolol
adrenergic beta-antagonists
drug therapy, combination
bendroflumethiazide
diuretics
treatment outcome
hypertension
Amlodipine Besylate
critical appraisal or critical reading

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Caduet-Fr.pdf
2006
false
Canada
French
Atorvastatin
drug combinations
cardiovascular diseases
canada
antihypertensive agents
amlodipine
hypertension
hyperlipidemias
amlodipine, atorvastatin drug combination
atorvastatin and amlodipine
drug evaluation
Amlodipine Besylate

---
https://minerva-ebp.be/fr/article/724
2006
false
false
minerva-ebm.be
Belgium
French
Valsartan
Valsartan
hypertension
amlodipine
amlodipine
antihypertensive agents
antihypertensive agents
calcium channel blockers
calcium channel blockers
cardiovascular diseases
treatment outcome
angiotensin II type 1 receptor blockers
Amlodipine Besylate
critical appraisal or critical reading
comparative study

---
https://minerva-ebp.be/fr/article/687
2006
false
false
minerva-ebm.be
Belgium
French
treatment outcome
amlodipine
coronary artery disease
calcium channel blockers
enalapril
angiotensin-converting enzyme inhibitors
cardiovascular diseases
Amlodipine Besylate
critical appraisal or critical reading
comparative study

---
https://minerva-ebp.be/fr/article/852
2005
false
false
minerva-ebm.be
Belgium
French
diabetes complications
angiotensin II type 1 receptor blockers
cardiovascular diseases
diabetes mellitus, type 2
treatment outcome
amlodipine
calcium channel blockers
placebos
diabetic nephropathies
biphenyl compounds
tetrazoles
antihypertensive agents
biphenyl compounds
tetrazoles
Amlodipine Besylate
critical appraisal or critical reading
comparative study
Irbesartan

---
http://www.has-sante.fr/portail/display.jsp?id=c_400768
2005
false
France
French
Atorvastatin
atorvastatin and amlodipine
drug combinations
amlodipine, atorvastatin drug combination
amlodipine
antihypertensive agents
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
calcium channel blockers
tablets
administration, oral
hypertension
cardiovascular diseases
risk factors
insurance, health, reimbursement
evaluation of the transparency committee
Amlodipine Besylate

---